Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Part of paid clinical trials in Camden, New Jersey.
- Sponsor
- The Cooper Health System
- Study ID
- NCT02749474
- Status
- Recruiting
Conditions
- Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
Key Dates
- Start date
- Jul 31, 2003
- Status verified
- Jun 2024
- Primary completion
- Jul 31, 2025
- Completion
- Jul 31, 2025
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Pregnant women diagnosed with cancerAny pregnant woman diagnosed with any cancer within 6 weeks prior to their last menstrual period, or up to 6 months after the end of their pregnancy can be enrolled.
Primary Outcome Measure
Neonatal Developmental Quotient [ Time Frame: Yearly from 3 months to 12 years of age ]
Central Contacts
- Elyce H Cardonick, MD856342 2065
- Harry Mazurek
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cooper University Hospital | Camden | New Jersey | 08103 |
Find similar trials in Camden, NJ
By research site